CN Patent

CN113813250B — 含氯胺酮的药物组合物及其制备方法和应用

Assigned to Guangzhou New Ji Pharmaceutical Co ltd · Expires 2023-05-05 · 3y expired

What this patent protects

本发明涉及一种含氯胺酮的药物组合物及其制备方法和应用。该含氯胺酮的药物组合物包括以下重量份的组分：氯胺酮16000～16500份；枸橼酸120～180份；乙二胺四乙酸盐5～15份；吸附剂40～100份；吐温80 2～8份；防腐剂0.1～4份；所述吸收剂为纤维素类吸附剂。本发明的含氯胺酮的药物组合物，通过鼻腔给药能实现很好的药效。

USPTO Abstract

本发明涉及一种含氯胺酮的药物组合物及其制备方法和应用。该含氯胺酮的药物组合物包括以下重量份的组分：氯胺酮16000～16500份；枸橼酸120～180份；乙二胺四乙酸盐5～15份；吸附剂40～100份；吐温80 2～8份；防腐剂0.1～4份；所述吸收剂为纤维素类吸附剂。本发明的含氯胺酮的药物组合物，通过鼻腔给药能实现很好的药效。

Drugs covered by this patent

esketamine-hydrochloride (ESKETAMINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN113813250B
Jurisdiction: CN
Classification: —
Expires: 2023-05-05
Drug substance claim: No
Drug product claim: No
Assignee: Guangzhou New Ji Pharmaceutical Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.